Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $4.17 million. The enterprise value is $3.63 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 21.48 million shares outstanding. The number of shares has increased by 194.35% in one year.
| Current Share Class | 21.48M |
| Shares Outstanding | 21.48M |
| Shares Change (YoY) | +194.35% |
| Shares Change (QoQ) | +82.54% |
| Owned by Insiders (%) | 2.37% |
| Owned by Institutions (%) | 4.95% |
| Float | 20.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -19.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87
| Current Ratio | 0.87 |
| Quick Ratio | 0.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -353.99 |
Financial Efficiency
Return on equity (ROE) is -714.95% and return on invested capital (ROIC) is -365.88%.
| Return on Equity (ROE) | -714.95% |
| Return on Assets (ROA) | -204.98% |
| Return on Invested Capital (ROIC) | -365.88% |
| Return on Capital Employed (ROCE) | 4,983.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.11M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.80% in the last 52 weeks. The beta is 0.87, so Oragenics's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -81.80% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 42.19 |
| Average Volume (20 Days) | 395,397 |
Short Selling Information
The latest short interest is 135,996, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 135,996 |
| Short Previous Month | 392,595 |
| Short % of Shares Out | 0.63% |
| Short % of Float | 0.65% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | -4.11M |
| Operating Income | -10.56M |
| Pretax Income | -19.52M |
| Net Income | -10.57M |
| EBITDA | -10.53M |
| EBIT | -10.56M |
| Earnings Per Share (EPS) | -$1.60 |
Full Income StatementBalance Sheet
The company has $864,840 in cash and $328,528 in debt, giving a net cash position of $536,312 or $0.02 per share.
| Cash & Cash Equivalents | 864,840 |
| Total Debt | 328,528 |
| Net Cash | 536,312 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | -211,885 |
| Book Value Per Share | -0.02 |
| Working Capital | -211,885 |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.60M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.60M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |